- AU$378.45m
- AU$220.88m
- AU$0.12m
Annual income statement for Immutep, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 7.77 | 0.313 | 0.254 | 0.192 | 0.12 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 28.8 | 21.1 | 34.4 | 45.1 | 50.5 |
| Operating Profit | -21 | -20.8 | -34.2 | -44.9 | -50.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -13.5 | -29.9 | -32.2 | -39.9 | -42.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -13.5 | -29.9 | -32.2 | -39.9 | -42.7 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -13.5 | -29.9 | -32.2 | -39.9 | -42.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -13.5 | -29.9 | -32.2 | -39.9 | -42.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.033 | -0.053 | -0.04 | -0.044 | -0.035 |